title: [Streptococcus pneumoniae infection and drug resistance in Japan].
abstract: In Japan, 7-valent pneumococcal conjugate vaccine was introduced in 2010. The population-based survey of invasive infection in child revealed that 62.7% of the S. pneumoniae isolates showed equal or more than 0.125 microg/mL of penicillin G MIC. ST320 with serotype 19A S. pneumoniae isolates showed 2-4 microg/mL and 0.25-0.5 microg/mL MICs of penicillin G and meropenem, respectively. The early introduction of PCV13 in Japan is anticipated.
authors.affiliation: Department of Internal Medicine, Nikko Citizen's Hospital.
authors.forename: Akihito
authors.initials: A
authors.lastname: Wada
mesh_terms: D000328:Adult; D002648:Child; D024881:Drug Resistance, Bacterial; D006801:Humans; D007564:Japan; D011008:Pneumococcal Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines; D013296:Streptococcus pneumoniae / Q000187:drug effects*
chemical_list: D022242:Pneumococcal Vaccines